Clinical trials for Cancer in United States

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Study ID: NCT06896162

Sponsor

UNC Lineberger Comprehensive Cancer Center

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Study ID: NCT05050162

Sponsor

NRG Oncology

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Study ID: NCT05423691

Sponsor

Cellenkos, Inc.

Novel Subtypes of Polycystic Ovary Syndrome

Study ID: NCT06124391

Sponsor

Shandong University

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Study ID: NCT06447662

Sponsor

Pfizer

Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Study ID: NCT06714591

Sponsor

SystImmune Inc.

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

Study ID: NCT06594991

Sponsor

Memorial Sloan Kettering Cancer Center

Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma

Study ID: NCT04626791

Sponsor

Academic and Community Cancer Research United

A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...

Study ID: NCT05621291

Sponsor

National Cancer Institute (NCI)

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

Study ID: NCT04471727

Sponsor

Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)